Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Adma Biologics (ADMA) Asset Utilization Ratio (2016 - 2025)

Adma Biologics' Asset Utilization Ratio history spans 14 years, with the latest figure at 0.86 for Q4 2025.

  • For Q4 2025, Asset Utilization Ratio fell 11.82% year-over-year to 0.86; the TTM value through Dec 2025 reached 0.86, down 11.82%, while the annual FY2025 figure was 0.92, 12.09% down from the prior year.
  • Asset Utilization Ratio reached 0.86 in Q4 2025 per ADMA's latest filing, down from 0.87 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.03 in Q2 2024 to a low of 0.22 in Q1 2021.
  • Average Asset Utilization Ratio over 5 years is 0.69, with a median of 0.74 recorded in 2022.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 139.58% in 2022, then dropped 13.5% in 2025.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.43 in 2021, then soared by 41.33% to 0.6 in 2022, then soared by 47.56% to 0.89 in 2023, then rose by 9.29% to 0.97 in 2024, then decreased by 11.82% to 0.86 in 2025.
  • Per Business Quant, the three most recent readings for ADMA's Asset Utilization Ratio are 0.86 (Q4 2025), 0.87 (Q3 2025), and 0.89 (Q2 2025).